buformin has been researched along with Kidney Diseases in 1 studies
Buformin: An oral hypoglycemic agent that inhibits gluconeogenesis, increases glycolysis, and decreases glucose oxidation.
buformin : A member of the class of biguanides that is biguanide substituted by a butyl group at position 1. It is an antidiabetic drug with potential antitumor effect.
Kidney Diseases: Pathological processes of the KIDNEY or its component tissues.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ritzl, F | 1 |
| Feinendegen, LE | 1 |
| Lintz, W | 1 |
| Tisljar, U | 1 |
1 other study available for buformin and Kidney Diseases
| Article | Year |
|---|---|
[Distribution and excretion of 14c-butylbiguanide in man (author's transl)].
Topics: Administration, Oral; Biguanides; Buformin; Feces; Humans; Injections, Intravenous; Intestinal Absor | 1978 |